ProShare Advisors LLC Has $147.55 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

ProShare Advisors LLC lessened its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 36.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 291,681 shares of the healthcare conglomerate’s stock after selling 165,391 shares during the period. ProShare Advisors LLC’s holdings in UnitedHealth Group were worth $147,550,000 as of its most recent filing with the SEC.

A number of other hedge funds also recently modified their holdings of UNH. Waycross Partners LLC lifted its holdings in UnitedHealth Group by 2.4% in the fourth quarter. Waycross Partners LLC now owns 27,794 shares of the healthcare conglomerate’s stock valued at $14,060,000 after buying an additional 658 shares during the period. Full Sail Capital LLC lifted its holdings in UnitedHealth Group by 2.1% in the fourth quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate’s stock valued at $815,000 after buying an additional 33 shares during the period. Lmcg Investments LLC lifted its holdings in UnitedHealth Group by 11.8% in the fourth quarter. Lmcg Investments LLC now owns 37,974 shares of the healthcare conglomerate’s stock valued at $19,210,000 after buying an additional 4,022 shares during the period. Seilern Investment Management Ltd bought a new stake in UnitedHealth Group in the fourth quarter valued at $153,015,000. Finally, Oregon Pacific Wealth Management LLC bought a new stake in UnitedHealth Group in the fourth quarter valued at $424,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Down 1.0%

UNH opened at $308.35 on Thursday. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The stock has a market cap of $279.72 billion, a price-to-earnings ratio of 19.89, a PEG ratio of 1.37 and a beta of 0.56. UnitedHealth Group Incorporated has a twelve month low of $284.25 and a twelve month high of $630.73. The company’s 50-day moving average price is $478.83 and its two-hundred day moving average price is $517.83.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). The company had revenue of $109.58 billion during the quarter, compared to analysts’ expectations of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same quarter in the previous year, the firm earned $6.91 earnings per share. As a group, equities analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were paid a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 2.72%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s payout ratio is currently 35.18%.

Analyst Ratings Changes

UNH has been the subject of several research analyst reports. Hsbc Global Res downgraded shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, April 22nd. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Argus downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Monday, April 21st. Robert W. Baird decreased their target price on shares of UnitedHealth Group from $510.00 to $356.00 and set an “outperform” rating for the company in a research report on Wednesday. Finally, Bank of America downgraded shares of UnitedHealth Group from a “buy” rating to a “neutral” rating and decreased their target price for the stock from $560.00 to $350.00 in a research report on Wednesday. Six analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $523.52.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.